HK1217721A1 - 用於從間-α抑制劑蛋白耗乏的血液製品材料中分離血液製品的方法 - Google Patents

用於從間-α抑制劑蛋白耗乏的血液製品材料中分離血液製品的方法

Info

Publication number
HK1217721A1
HK1217721A1 HK16105783.2A HK16105783A HK1217721A1 HK 1217721 A1 HK1217721 A1 HK 1217721A1 HK 16105783 A HK16105783 A HK 16105783A HK 1217721 A1 HK1217721 A1 HK 1217721A1
Authority
HK
Hong Kong
Prior art keywords
methods
product material
inhibitor protein
alpha inhibitor
isolating
Prior art date
Application number
HK16105783.2A
Other languages
English (en)
Inventor
Yow-Pin Lim
Original Assignee
Prothera Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51208188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1217721(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prothera Biologics Inc filed Critical Prothera Biologics Inc
Publication of HK1217721A1 publication Critical patent/HK1217721A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK16105783.2A 2013-01-18 2016-05-20 用於從間-α抑制劑蛋白耗乏的血液製品材料中分離血液製品的方法 HK1217721A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361754366P 2013-01-18 2013-01-18
PCT/US2014/012033 WO2014113659A1 (en) 2013-01-18 2014-01-17 Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material

Publications (1)

Publication Number Publication Date
HK1217721A1 true HK1217721A1 (zh) 2017-01-20

Family

ID=51208188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105783.2A HK1217721A1 (zh) 2013-01-18 2016-05-20 用於從間-α抑制劑蛋白耗乏的血液製品材料中分離血液製品的方法

Country Status (8)

Country Link
US (2) US20140206844A1 (zh)
EP (1) EP2945962B1 (zh)
CN (1) CN105209477A (zh)
AU (1) AU2014207447B2 (zh)
CA (1) CA2921692A1 (zh)
ES (1) ES2736283T3 (zh)
HK (1) HK1217721A1 (zh)
WO (1) WO2014113659A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
AU2009260822B2 (en) 2008-05-28 2016-09-22 Prothera Biologics, Inc. Preparation and composition of Inter-alpha inhibitor proteins from blood
CA2885604A1 (en) * 2012-09-09 2014-03-13 Prothera Biologics, Inc. Treatment of ischemia using inter-alpha inhibitor proteins
CN108144586B (zh) * 2016-12-05 2020-07-17 中国水产科学研究院黄海水产研究所 对氨基苯甲脒仿生亲和配基的仿生亲和纯化方法
IL296778A (en) 2020-03-31 2022-11-01 Takeda Pharmaceuticals Co A method for producing an immunoglobulin composition from diluted c-1 inhibitor plasma
CN112028988A (zh) * 2020-10-16 2020-12-04 哈尔滨派斯菲科生物制药股份有限公司 一种冻干型人凝血因子viii的制备方法
AU2021377336A1 (en) 2020-11-16 2023-07-06 Prothera Biologics, Inc. Methods for purifying inter-alpha inhibitor proteins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT368883B (de) 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
AT379310B (de) 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
EP0317376B2 (fr) 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
GB8729822D0 (en) 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
EP1326893A2 (de) * 2000-10-13 2003-07-16 Octapharma AG Bikunin enthaltende plasmafraktion, verfahren zu ihrer herstellung und ihrer verwendung
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
US9624260B2 (en) * 2004-06-07 2017-04-18 Therapure Biopharma Inc. Process for isolation of plasma or serum proteins
GB0524432D0 (en) 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
CN101274956B (zh) 2008-04-11 2011-10-05 三九集团湛江开发区双林药业有限公司 从人血浆组分FIV沉淀中分离纯化α1-抗胰蛋白酶的方法
AU2009260822B2 (en) 2008-05-28 2016-09-22 Prothera Biologics, Inc. Preparation and composition of Inter-alpha inhibitor proteins from blood
US9127043B2 (en) 2009-03-05 2015-09-08 Biogen Ma Inc. Purification of immunoglobulins
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
SG187599A1 (en) * 2010-07-23 2013-03-28 Baxter Int Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma

Also Published As

Publication number Publication date
AU2014207447B2 (en) 2018-11-15
EP2945962A4 (en) 2016-11-02
US20140206844A1 (en) 2014-07-24
WO2014113659A1 (en) 2014-07-24
US20150361127A1 (en) 2015-12-17
CN105209477A (zh) 2015-12-30
EP2945962A1 (en) 2015-11-25
ES2736283T3 (es) 2019-12-27
AU2014207447A1 (en) 2015-09-03
EP2945962B1 (en) 2019-04-17
CA2921692A1 (en) 2014-07-24

Similar Documents

Publication Publication Date Title
HK1231532A1 (zh) 高松密度紙製品
IL247508A0 (en) A method for preparing human plasma proteins
HK1217721A1 (zh) 用於從間-α抑制劑蛋白耗乏的血液製品材料中分離血液製品的方法
SG11201703178YA (en) Method for ketonisation of biological material
ZA201309660B (en) Device for the accumulation of products
ZA201406908B (en) Method and device for the hydroformylation of isobutene and for the separation of the product mixture
EP2995395A4 (en) SURFACE PROCESSING WITH SURFACE CORRFINDERING AND HOT SHEARING PRODUCT WITH SURFACE CORNFINERATION
GB201320066D0 (en) Biological products
PL3072117T3 (pl) Sposób frakcjonowania materiałów lignocelulozowych
EP2998740A4 (en) METHOD FOR PREDICTING THE CLINICAL EFFECT OF IMMUNOTHERAPY
IL244455A0 (en) hemostatic products
IL248283B (en) Method for the synthesis of clofarabine
EP2968057A4 (en) PACKAGING FOR A MEDICAL DEVICE
PL2942300T3 (pl) Sposób pakowania do pakowania artykułu będącego przedmiotem handlu
EP2969870A4 (en) METHOD FOR DISTRIBUTING SOLID PRODUCTS
PL2719720T3 (pl) Sposób modyfikacji powierzchni wyrobu z elastomeru
ZA201700618B (en) Apparatus for the separation of agricultural products
ZA201502960B (en) Processes for the preparation of an olefinic product
EP3221706A4 (en) Methods and products for labelling lipids
EP3128327A4 (en) Method for detecting smn protein expression
SG11201503328SA (en) Processes for the preparation of an olefinic product
PL2912051T3 (pl) Sposób rozdzielania białek zawierających domenę wiążącą albuminę
HK1219477A1 (zh) 合成含有乙內酰脲的肽產物
GB2530339B (en) Packaging for containing and displaying products
PL2951143T3 (pl) Sposób karbonylowania olefin